This article was written by Follow Buyside analyst covering global stocks on Seeking Alpha since 2018. I’ve been investing personally and professionally across major...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
Amid stiff competition in a generally saturated market, American oral care giant Colgate-Palmolive (NYSE:CL) has delivered marginal growth over the past several years. A...
Introduction Aldeyra Therapeutics (NASDAQ:ALDX) is a biotech firm focused on creating therapies for immune-mediated diseases. Their groundbreaking RASP (reactive aldehyde species) pharmaceutical platform targets...
On July 6, 2023, the Food and Drug Administration granted full approval to Biogen (NASDAQ:BIIB) and Eisai’s (OTCPK:ESALF, OTCPK:ESAIY) anti-amyloid antibody drug Leqembi. For...
Written by Nick Ackerman, co-produced by Stanford Chemist. This article was originally published to members of the CEF/ETF Income Laboratory on June 25th, 2023....